Morphological, dynamic and functional characteristics of liver pseudolesions and benign lesions
- PMID: 35028886
- DOI: 10.1007/s11547-022-01449-w
Morphological, dynamic and functional characteristics of liver pseudolesions and benign lesions
Abstract
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths worldwide and one of the most common causes of death among patients with cirrhosis, developing in 1-8% of them every year, regardless of their cirrhotic stage. The radiological features of HCC are almost always sufficient for reaching the diagnosis; thus, histological confirmation is rarely needed. However, the study of cirrhotic livers remains a challenge for radiologists due to the developing of fibrous and regenerative tissue that cause the distortion of normal liver parenchyma, changing the typical appearances of benign lesions and pseudolesions, which therefore may be misinterpreted as malignancies. In addition, a correct distinction between pseudolesions and malignancy is crucial to allow appropriate targeted therapy and avoid treatment delays.The present review encompasses technical pitfalls and describes focal benign lesions and pseudolesions that may be misinterpreted as HCC in cirrhotic livers, providing the imaging features of regenerative nodules, large regenerative nodules, siderotic nodules, hepatic hemangiomas (including rapidly filling and sclerosed hemangiomas), segmental hyperplasia, arterioportal shunts, focal confluent fibrosis and focal fatty changes. Lastly, the present review explores the most promising new imaging techniques that are emerging and that could help radiologists differentiate benign lesions and pseudolesions from overt HCC.
Keywords: Cirrhosis; Diagnosis; Hepatocellular carcinoma; Magnetic resonance imaging; Neoplasms.
© 2022. Italian Society of Medical Radiology.
References
-
- Vilgrain V, Lagadec M, Ronot M (2016) Pitfalls in liver imaging. Radiology 278(1):34–51. https://doi.org/10.1148/radiol.2015142576 - DOI - PubMed
-
- Ioannou GN, Splan MF, Weiss NS, McDonald GB, Beretta L, Lee SP (2007) Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol 5:938–945. https://doi.org/10.1016/j.cgh.2007.02.039 - DOI - PubMed
-
- Guarino M, Sessa A, Cossiga V, Morando F, Caporaso N, Morisco F (2018) Special Interest Group on “Hepatocellular carcinoma and new anti-HCV therapies” of the Italian Association for the Study of the Liver. Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows. World J Gastroenterol 24(24):2582–2595. https://doi.org/10.3748/wjg.v24.i24.2582 - DOI - PubMed - PMC
-
- Mittal S, El-Serag HB (2013) Epidemiology of hepatocellular carcinoma: consider the population. J Clin Gastroenterol 47(Suppl(0)):S2-6. https://doi.org/10.1097/MCG.0b013e3182872f29 - DOI - PubMed - PMC
-
- Cucchetti A, Trevisani F, Cappelli A, Mosconi C, Renzulli M, Pinna AD, Golfieri R (2016) Cost-effectiveness of doxorubicin-eluting beads versus conventional trans-arterial chemo-embolization for hepatocellular carcinoma. Dig Liver Dis 48(7):798–805. https://doi.org/10.1016/j.dld.2016.03.031 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
